Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer
Clinical trial NCT07619365 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07619365
- Sponsor
- Washington University School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2030-08-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.